Skip to content

Azenta

US · AZTA #2893 by market cap Listed 1970
44.80 -2.29 -4.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Financial Health how this is computed

Good
  • Altman Z-Score is 5.25, above the 3.0 "safe zone" threshold.
  • Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail
  • Sample Management Solutions is the largest reported line at 54.78% of revenue, across 2 reported segments.
  • Multiomics follows at 45.22%, so the top line still matters most but isn’t the whole story.

Revenue annual, last 8 years

Latest year +4.70% YoY

Margins

Gross margin
44.23%
Operating margin
-3.29%
Net margin
-26.86%

Key ratios & quality

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item 2019 2020 2021 2022 2023 2024 2025 2026
Revenue 334.18M388.54M513.70M555.50M551.49M573.45M593.82M621.70M
Gross profit 134.60M172.15M243.81M255.58M239.21M254.62M270.28M274.96M
Selling & admin expenses 163.33M190.26M252.10M251.47M263.74M262.96M261.56M257.53M
Research & development 17.32M17.82M22.41M27.54M32.14M31.52M30.39M37.92M
Operating profit -46.04M-35.93M-30.70M-23.42M-56.67M-39.86M-21.67M-20.48M
Pretax profit -83.96M-40.29M-48.97M-9.94M-20.01M-19.13M-7.14M-151.01M
Tax -22.83M-13.93M-20.10M1.35M-11.97M5.24M-31.60M6.86M
Net profit 437.42M64.85M110.75M2.13B-14.64M-164.90M-55.76M-166.99M
Basic EPS 611280-3-1-4
Diluted EPS 6.040.881.4928.48-0.22-3.10-1.22-3.70

Balance sheet

Line item 2019 2020 2021 2022 2023 2024 2025 2026
Total current assets 647.15M649.45M777.37M2.46B1.42B833.03M708.34M623.54M
Cash & ST investments 335.77M250.70M227.51M1.57B1.02B431.19M340.92M332.68M
Inventory 99.45M37.13M60.40M85.54M128.20M71.32M74.96M77.12M
Total assets 1.52B1.56B1.82B3.72B2.89B2.10B2.06B1.71B
Total current liabilities 272.27M211.12M345.09M230.55M210.93M206.09M237.67M233.09M
Short-term debt 829.00K827.00K------------
Long-term debt 50.32M49.59M49.68M----------
Total liabilities 377,045,000.00345,651,000.00494,178,000.00352,736,000.00351,220,000.00332,418,000.00332,596,000.00311,162,000.00
Total equity 1.14B1.21B1.33B3.36B2.53B1.77B1.73B1.40B
Retained earnings -586.41M-551.07M-470.05M1.66B1.64B1.48B1.42B1.25B

Cash flow

Line item 2019 2020 2021 2022 2023 2024 2025 2026
Operating cash flow 90.90M37.87M149.86M-466.05M5.83M49.74M72.18M57.51M
Depreciation & amortization 54.45M65.50M65.33M53.70M85.58M90.74M61.21M56.52M
Free cash flow 67.04M-2.06M97.05M-543.48M-33.60M12.35M38.32M27.43M
Dividends paid -28.90M-29.51M-29.73M-7.49M--------
Stock buybacks / issuance 3.42M4.60M5.81M5.25M-834.89M-658.42M2.77M-116.08M
Ending cash balance 305.17M302.53M285.33M1.04B684.05M320.99M296.69M198.32M

Returns & efficiency

Line item 2019 2020 2021 2022 2023 2024 2025 2026
ROE % 47.125.518.7290.98-0.48-7.63-3.19-10.69
ROA % 33.504.226.5677.06-0.43-6.59-2.68-8.86
ROIC % 43.025.368.2387.79-1.56-8.90-3.87-11.01
5-year avg ROE % 13.2013.8617.9533.9830.3719.4117.67--
EBIT margin % 4.068.68-9.14-0.96-4.58-11.11-3.65-3.29
FCF / sales % 8.59--18.89----1.976.454.41
Current ratio 2.383.082.2510.676.734.042.982.68
Quick ratio 1.841.641.017.525.572.962.072.23
Debt / assets 3.374.455.211.322.092.702.493.04
LT debt / equity 4.425.647.151.462.383.212.973.71
Interest coverage 1.4226.47-23.04-1.17--------
Revenue CAGR (3Y) % -8.34-9.69-6.6518.4612.383.742.25-2.22
Net income CAGR (3Y) % --1.18-1.7069.57--------
FCF CAGR (3Y) % 35.92--16.63-----49.70----

Revenue breakdown most recent period

Business

Sample Management Solutions54.78%
Multiomics45.22%

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Azenta discussion 0 comments

Add a comment